UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medical cannabis imports allowed only through orphan drug center
As Korea moves to allow medical marijuana imports for self-treatment purpos...
by Lee Hye-seon
|
2019-02-22 10:55
라인
International groups praise Korea’s dementia-combating efforts
Officials from international organizations, including the World Health Orga...
by Lee Han-soo
|
2019-02-21 15:28
라인
Korea to revise limited exclusive sales rights approval
The Ministry of Food and Drug Safety said it was pushing to amend the limit...
by Lee Hye-seon
|
2019-02-21 11:28
라인
Regulator to inspect 12 biopharmaceutical plants overseas
The Ministry of Food and Drug Safety said it would conduct a regular inspec...
by Lee Hye-seon
|
2019-02-20 16:18
라인
Government to spend ₩3 trillion on innovative drugs, dementia, medical scientists
The government will invest about 3 trillion won ($2.67 billion) in biotech ...
by Kwak Sung-sun
|
2019-02-20 11:44
라인
Korea to raise vaccine self-sufficiency to 57% by 2020
The Ministry of Food and Drug Safety said it would build a state-run techno...
by Lee Hye-seon
|
2019-02-19 14:47
라인
Korea spreads health insurance system to Asia
Korea’s efforts to promote the excellence of its health insurance system am...
by Lee Han-soo
|
2019-02-19 12:37
라인
‘Innovative’ drugmakers to invest ₩1.7 trillion in developing new drugs
Forty-three out of the 47 government-designated innovative drugmakers will ...
by Lee Han-soo
|
2019-02-14 11:26
라인
WHO to revise criteria for personality disorder for 1st time in three decades
The World Health Organization is expected to change the diagnostic codes of...
by Lee Hye-seon
|
2019-02-13 12:16
라인
Direct-to-consumer genetic testing allowed for Parkinson’s, lung cancer
The government has decided to include direct-to-consumer genetic testing in...
by Park Gi-taek
|
2019-02-12 14:48
라인
US pharma group asks USTR to designate Korea as priority foreign country
The Pharmaceutical Research and Manufacturers of America (PhRMA) said it ha...
by Lee Han-soo
|
2019-02-11 17:49
라인
Seoul goes all out to promote Korean healthcare in Middle East
Minister of Health and Welfare Park Neung-hoo returned from his three-day t...
by Lee Han-soo
|
2019-01-29 18:56
라인
Government to tighten rule for drug license renewal
The government will not allow renewal of drug approval if a company manufac...
by Lee Hye-seon
|
2019-01-29 12:51
라인
Korea to set up new review process for advanced medical devices
The Ministry of Food and Drug Safety said it would enhance drug safety mana...
by Lee Hye-seon
|
2019-01-28 17:35
라인
Government to expand insurance coverage for MRI
The Ministry of Health and Welfare announced it would extend health insuran...
by Lee Han-soo
|
2019-01-28 17:02
라인
Two CROs reprimanded for delayed reports of adverse events
The Ministry of Food and Drug Safety issued a warning to two clinical resea...
by Lee Hye-seon
|
2019-01-24 15:40
라인
‘Trade deal with US makes it hard for Seoul to support local drugmakers’
Health and Welfare Minister Park Neung-hoo said he felt frustrated about no...
by Kwak Sung-sun
|
2019-01-23 15:31
라인
Court suspends FSC’s disciplinary ruling against Samsung BioLogics
The Seoul Administrative Court has suspended the Financial Services Commiss...
by Lee Han-soo
|
2019-01-22 22:30
라인
Seoul’s disease control questioned amid spreading fears over measles
Experts are raising concerns that the Korean government’s epidemic preventi...
by Choi Gwang-seok
|
2019-01-22 15:16
라인
Top Court’s ruling affects local companies’ base-altering strategies to avoid patents
Local pharmaceutical companies may no longer be able to avoid patent claims...
by Lee Han-soo
|
2019-01-18 16:36
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top